Company Overview
Dong Kook Lifescience as a subsidiary company of Dong Kook Pharmaceutical, follows the core values of founder
and the late Chairman Dong Il Kwon, which are Creativity, Harmony and Credibility.
Creation
We adapt to new environment and situation
and provide new solutions to the market in
advance.
and provide new solutions to the market in
advance.
Communication
We communicate actively in order to identify
the needs of consumers and stakeholders at
every contact point.
the needs of consumers and stakeholders at
every contact point.
Care
Honest and sincere social contribution and
upright management.
upright management.
-
Diagnostic medicineDong Kook Lifescience strives to strategically expand its markets with leading ethical product portfolio, the main driving engine for the company’s growth.
These include Megaray (Gadopentetate Dimeglumine: MRI contrast media) and Pamiray (Iopamidol : X-ray contrast media) that its API in synthesized by Dong Kook Lifescience and they are also exported to 17 countries including EU, Japan and Asian market.
With constant development of new products, Dong Kook Lifescience will keep extending markets and products. -
Diagnostic medical deviceDong Kook Lifescience has two medical device categories with Mobile CT Smart M and Ultrasound device.
Mobile CT Smart M™ is quick to obtain the image from the scan to image reconstruction with low Dose. It has the superior Image Quality which comes from 360˚ scanning technology.
Dong Kook’s Ultrasound device manufactured by SIEMENS Healthineers is Color Doppler Ultrasound system which enables fast and accurate diagnosis of diseases such as vascular diseases, abdominal organs, thyroid, breast, heart and musculoskeletal system. -
Global NetworkDong Kook Lifescience has build up the global networks in over 17 countries including EU and Japan.
In 2016, we achieved US$20 Million in overseas sales with API such as Iopamidol (X-ray contrast media), Cilastatin (Antibiotic) and finished products Pamiray (X-ray contrast media), Megaray (MRI contrast media).
Especially, Dong Kook Lifescience is expanding global networks further with commitment to sustainable development of products that are focused on advanced countries. -
Research & DevelopmentWith keen awareness of importance of R&D, Dong Kook Lifescience is dedicated to making continual progress in R&D innovations and continually develops the new products by investing average 5% of total revenue. Our competencies are being focused to secure an unrivalled position in rapidly changing global markets, by conducting technology-intensive, market and customer-centered development project as well as advancing existing expertise and technology.